Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

2.

SV40 and cell cycle perturbations in malignant mesothelioma.

Testa JR, Giordano A.

Semin Cancer Biol. 2001 Feb;11(1):31-8. Review.

PMID:
11243897
3.

The pathogenesis of mesothelioma.

Carbone M, Kratzke RA, Testa JR.

Semin Oncol. 2002 Feb;29(1):2-17. Review.

PMID:
11836664
4.

Pathogenesis of malignant pleural mesothelioma.

Jaurand MC, Fleury-Feith J.

Respirology. 2005 Jan;10(1):2-8. Review.

PMID:
15691231
5.

Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas.

Schrump DS, Waheed I.

Semin Cancer Biol. 2001 Feb;11(1):73-80. Review.

PMID:
11243901
6.

SV40-mediated immortalization of human fibroblasts.

Ozer HL, Banga SS, Dasgupta T, Houghton J, Hubbard K, Jha KK, Kim SH, Lenahan M, Pang Z, Pardinas JR, Patsalis PC.

Exp Gerontol. 1996 Jan-Apr;31(1-2):303-10. Review.

PMID:
8706800
7.

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.

Ahuja D, Sáenz-Robles MT, Pipas JM.

Oncogene. 2005 Nov 21;24(52):7729-45. Review.

PMID:
16299533
8.

Simian virus 40 and human tumors: It is time to study mechanisms.

Carbone M.

J Cell Biochem. 1999 Dec;76(2):189-93. Review.

PMID:
10618636
9.

Animal models of malignant mesothelioma.

Kane AB.

Inhal Toxicol. 2006 Nov;18(12):1001-4. Review.

PMID:
16920675
10.

Bleomycin and its role in inducing apoptosis and senescence in lung cells - modulating effects of caveolin-1.

Kasper M, Barth K.

Curr Cancer Drug Targets. 2009 May;9(3):341-53. Review.

PMID:
19442053
11.

New molecular and epidemiological issues in mesothelioma: role of SV40.

Carbone M, Fisher S, Powers A, Pass HI, Rizzo P.

J Cell Physiol. 1999 Aug;180(2):167-72. Review.

PMID:
10395286
12.

[SV40: a possible co-carcinogen of asbestos in the pathogenesis of mesothelioma?].

Cristaudo A, Foddis R, Bigdeli L, Vivaldi A, Buselli R, Guglielmi G, Guidi M, Ottenga F.

Med Lav. 2002 Nov-Dec;93(6):499-506. Review. Italian.

PMID:
12596420
13.

Role of T antigen interactions with p53 in tumorigenesis.

Pipas JM, Levine AJ.

Semin Cancer Biol. 2001 Feb;11(1):23-30. Review.

PMID:
11243896
14.

An oncogene-induced DNA damage model for cancer development.

Halazonetis TD, Gorgoulis VG, Bartek J.

Science. 2008 Mar 7;319(5868):1352-5. doi: 10.1126/science.1140735. Review.

PMID:
18323444
15.

SV40 large T-antigen disturbs the formation of nuclear DNA-repair foci containing MRE11.

Digweed M, Demuth I, Rothe S, Scholz R, Jordan A, Grötzinger C, Schindler D, Grompe M, Sperling K.

Oncogene. 2002 Jul 25;21(32):4873-8. Review.

16.

Simian virus 40 infection in humans and association with human diseases: results and hypotheses.

Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M.

Virology. 2004 Jan 5;318(1):1-9. Review.

PMID:
15015494
17.

SV40-Mediated immortalization.

Jha KK, Banga S, Palejwala V, Ozer HL.

Exp Cell Res. 1998 Nov 25;245(1):1-7. Review.

PMID:
9828095
18.

[Disturbance of the normal cell cycle by T antigens of SV40 viruses and JC cause some tumors].

Kryńska B, Lewin-Kowalik J, Sieroń AL.

Postepy Hig Med Dosw. 1998;52(3):237-57. Review. Polish.

PMID:
9789434
19.

Induction of senescent-like growth arrest as a new target in anticancer treatment.

Wang X, Tsao SW, Wong YC, Cheung AL.

Curr Cancer Drug Targets. 2003 Apr;3(2):153-9. Review.

PMID:
12678717
20.

The pathogenesis of mesothelioma.

Carbone M, Bedrossian CW.

Semin Diagn Pathol. 2006 Feb;23(1):56-60. Review.

PMID:
17044196

Supplemental Content

Support Center